Format

Send to

Choose Destination
Expert Rev Mol Diagn. 2015 Feb;15(2):153-6. doi: 10.1586/14737159.2015.1002470.

Companion diagnostics: the key to personalized medicine. Foreword.

Author information

1
Dx-Rx Institute, Baunevaenget 76, 3480 Fredensborg, Denmark.

Abstract

This special focus issue of Expert Review of Molecular Diagnostics on in vitro companion diagnostics aims to provide the reader with up-to-date knowledge on this fast-evolving area of medical research. Companion diagnostics takes up a central role in the development of targeted drugs and to a large extent, the success of this type of therapy depends on their performance. Companion diagnostic assays have a single patient as a point of reference and they will be decisive for the move toward a more precise and individualized pharmacotherapy. The 'first generation' of companion diagnostic assays relies on single biomarker detection but with our increasing understanding of disease pathophysiology a new generation of assays is under development, which will be based on patient profiling and multiplex platforms.

KEYWORDS:

companion diagnostics; oncology; personalized medicine; precision medicine; rheumatology

PMID:
25597758
DOI:
10.1586/14737159.2015.1002470
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center